Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Evaluation of the effect of modifying indocyanine green solvent on its toxicity to the corneal endothelial cells
Author Affiliations & Notes
  • Aidan Rubio
    Ophthalmology, Stanford University, Stanford, California, United States
  • Jia-Horung Hung
    Ophthalmology, Stanford University, Stanford, California, United States
    Ophthalmology, National Cheng Kung University Hospital, Tainan, Tainan, Taiwan
  • Sheng-Hsiang Lin
    Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan
  • Iou-Jih Hsu
    Department of Family and Community Medicine, E-Da Hospital, Yanchao, Kaohsiung, Taiwan
  • Yi-Sheng Chang
    Ophthalmology, National Cheng Kung University Hospital, Tainan, Tainan, Taiwan
  • Sheng-Min Hsu
    Ophthalmology, National Cheng Kung University Hospital, Tainan, Tainan, Taiwan
  • Zheng Xian Thng
    Ophthalmology, Stanford University, Stanford, California, United States
  • Amir Akhavanrezayat
    Ophthalmology, Stanford University, Stanford, California, United States
  • S. Saeed Mohammadi
    Ophthalmology, Stanford University, Stanford, California, United States
  • Woong-Sun Yoo
    Ophthalmology, Stanford University, Stanford, California, United States
  • Cigdem Yasar
    Ophthalmology, Stanford University, Stanford, California, United States
  • Anh Ngoc Tram Tran
    Ophthalmology, Stanford University, Stanford, California, United States
  • Ankur Sudhir Gupta
    Ophthalmology, Stanford University, Stanford, California, United States
  • Li-Wha Wu
    Institute of Molecular Medicine, National Cheng Kung University, Tainan, Taiwan
    Laboratory Science and Technology,, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Quan Dong Nguyen
    Ophthalmology, Stanford University, Stanford, California, United States
  • Footnotes
    Commercial Relationships   Aidan Rubio None; Jia-Horung Hung None; Sheng-Hsiang Lin None; Iou-Jih Hsu None; Yi-Sheng Chang None; Sheng-Min Hsu None; Zheng Thng None; Amir Akhavanrezayat None; S. Saeed Mohammadi None; Woong-Sun Yoo None; Cigdem Yasar None; Anh Tran None; Ankur Sudhir Gupta None; Li-Wha Wu None; Quan Nguyen Acelyrin, Code F (Financial Support), Priovant, Code F (Financial Support), Belite Bio, Code F (Financial Support), Boeringer-Ingelheim, Code F (Financial Support), Oculis, Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2088. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aidan Rubio, Jia-Horung Hung, Sheng-Hsiang Lin, Iou-Jih Hsu, Yi-Sheng Chang, Sheng-Min Hsu, Zheng Xian Thng, Amir Akhavanrezayat, S. Saeed Mohammadi, Woong-Sun Yoo, Cigdem Yasar, Anh Ngoc Tram Tran, Ankur Sudhir Gupta, Li-Wha Wu, Quan Dong Nguyen; Evaluation of the effect of modifying indocyanine green solvent on its toxicity to the corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2088.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ensuring optimal visibility of the anterior capsule is crucial in continuous curvilinear capsulorhexis (CCC) during cataract surgery, particularly in advanced cataracts with diminished red reflex from the retina. Furthermore, the unavailability of the commonly proposed agents trypan blue and Brilliant blue G in some operating theaters prompts exploration of indocyanine green (ICG) as a viable vital dye, given its ability to stain the lens capsule. In the index retrospective study, we assessed the effects of modifying the ICG solvent on reducing its toxicity.

Methods : Eyes undergoing phacoemulsification and intraocular lens implantation performed by a single surgeon between September 2017 and March 2018 at National Cheng Kung University Hospital were reviewed. Patients were categorized into three groups: a control group without ICG, a group with ICG dissolved in distilled water (ICGDW), and a group with ICG dissolved in 5% glucose water (ICGGW). ICG concentration was 0.25% in both solutions. The primary endpoint was a change in endothelial cell density (ECD), measured at postoperative 1- or 3-months. In vitro experiments involved harvesting rabbit corneal endothelium cells treated with different solutions for one minute, with cellular toxicity assessed using a lactate dehydrogenase assay.

Results : After inverse probability of treatment weighting adjustments, one hundred eyes of 63 patients with similar cataract grading across the three groups were included. There are 26, 43, and 31 eyes in the ICGDW, ICGGW, and control groups, respectively. Preoperative ECD and central corneal thickness and cumulative dissipated energy were comparable among the group (Figure 1). ECD reduction at the 1- and 3-month postoperative visits was significantly higher in the ICGDW group compared to the control or ICGGW group (p<0.05 for both time points). Eyes operated using ICGDW presented a higher risk of more than 5% endothelial cell density loss at three months (OR 75.13, 95% CI: 7.46-756.06). Cellular experiments demonstrated significantly lower cellular survival after treatment with distilled or ICGDW (Figure 2).

Conclusions : The study indicates that the toxicity of the ICG solution is partially attributed to the solvent, with 5% glucose water being a safer solvent than distilled water. This finding can assist surgeons in selecting vital dyes for selected cases of advanced cataract.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×